Resistance majority

Pascual-Leone, A., Rubio, B., Pallardo, R, and Catala, M.D. (1996) Rapid-rate trancranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant major depression. Lancet 34S 233-237. 

Birmaher, B., Waterman, G.S., Ryan, N.D., Perel, J., McNabb, J., Balach, L., Beaudry, M.B., Nasr, F.N., Karambelkar, J., Elterich, G., Quintana, H., Williamson, D.E., and Rao, U. (1998) Randomized, controlled trial of amitriptyline versus placebo for adolescents with treatment-resistant major depression. J Am Acad Child Adolesc Psychiatry 37 527-535. 

Psychiatr Chn North Am 19 179-200, 1996 Fava M, Rosenbaum JF, McGrath PJ, et al Dthium and tricyclic augmentation of fluoxetine treatment for resistant major depression a double-blind, controlled study. Am J Psychiatry 151 1372-1374, 1994 Fawcett J Suicide risk factors in depressive disorders and panic disorder. J Clin Psychiatry 53 [suppl 3) 9-13, 1992... 

Nolen WA, Haffmans PMJ, Bouvy PF, et al Monoamine oxidase inhibitors in resistant major depression. J Affect Disord 28 189-197, 1993 Nomikos GC, Damsma G, Wenkstern D, et al Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens. Eur J Pharmacol 195 63-73, 1991 Nomikos GC, Damsma D, Wenkstern D, et al Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 7 7-14, 1992... 

Marangeh LB Switching antidepressants for treatment-resistant major depression. J Clin Psychiatry 62 (suppl 18) 12-17, 2001... 

Lithium Lithium augmentation of standard antidepressants has been reported to significantly benefit previously treatment-resistant and psychotic depressions, particularly in bipolar patients ( 371, 372). There is substantial case report literature reporting that many patients have benefited when lithium was added to ongoing TCA therapy. Often these results occurred rapidly, sometimes with low doses of lithium. Although the results of controlled trials have not been as dramatic, they still support this approach, which should be seriously considered for treatment-resistant major depression. 

McGrath PJ, Fava M, Stewart JW, et al. Bupropion SR for SSRI-resistant major depression. 40th Annual Meeting NCDEU, Boca Raton, Florida, 2000, Poster 10(abst). 

Fava M, Rosenbaum JF, McGrath PJ, et al. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression A double-blind, controlled study. Am J Psychiatry 1994 151 1372-1374. 

Hofiich G, Kasper S, Ruhrmann S, et ai. Appiication of transcraniai magnetic stimuiation in treatment of drug resistant major depression -a report of two cases. Hum Psychopharmacoi 1993 8 361-365. 

J Garcia-Bustos, A Tomasz. A biological price of antibiotic resistance major changes in the peptidoglycan structure of penicillin-resistant strains of Streptococcus pneumoniae. Proc Natl Acad Sci (USA) 87 5414-5419, 1990. 

Papakostas, G. I., Petersen, T. J., Kinrys, G., Bums, A. M., Worthington, J. J., Alpert, J. E., Fava, M. Nierenberg, A. A. (2005). Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. J. Clin. Psychiatry, 66, 1326-1330. 

Barbee JG, Comad EJ, Jamhour NJ. The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder. J Clin Psychiatry 2004 65(7) 975-981. 

The addition of lithium to other drug therapy has been studied in 92 patients with treatment-resistant major depression taking nortriptyline (97). Non-responders to nortriptyline (n = 35) were randomized to added lithium or placebo there was no significant difference. 

Well accepted for use in schizophrenia and bipolar disorder, including difficult cases Documented utility in treatment-refractory cases, especially at higher doses Documented efficacy as augmenting agent to SSRIs (especially fluoxetine) in nonpsychotic treatment-resistant major depressive disorder Documented efficacy in bipolar depression, especially in combination with fluoxetine... 

Zarate CA, Singh IB, Carlson PJ, Brutsche NE, Ameli R, Luck-enbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006 63 856-864. 

Zar ate CA, Jr., Payne JL, Quiroz J, Spoin J, Denicoff KK, Lucken-baugh D, Charmey DS, Manji HK (2004) An open-label tidal of riluzole in patients witli ti eatment-resistant major depression. Am J Psyclriati y 161 171—174. 

The analysed parameters are pH, resistivity, major cations and anions, total organic carbon and nitrogen, phosphorus, silica, aluminium and iron. The results show ... 

Nelson JC. Managing treatment resistant major depression, j Clin Psychiatry 2003 64 5-12. 

Most of the tests done to determine the fastness properties caused severe deterioration of the microcapsules, except for the mbbing, in which the microcapsules resisted major damage from the Crock-meter and retained most of their thermochromic capabilities. 

Barbosa, L., Berk, M., and Vorster, M. 2003. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J. Clin. Psychiatry 64 403 07. 

Heresco-Levy, U., Javitt, D.C., Gelfin, Y., Gorelik, E., Bar, M., Blanaru, M., and Kremer, 1. 2006. Controlled trial of d-cycloserine adjuvant therapy for treatment-resistant major depressive disorder. J. Affect. Disord. 93 239-243. 

Standing heat resistance. Major uses indude transportation crates, caps, blow-molded containers and films. For injection molded HOPE, new types have become available enabling warp-free formulations to be produced. Selected grades are suitable for food packaging and toys, and meet national and international regulations induding FDA (USA), FPL (France), BgW (Germany) JHP/JHOSPA (Japan), TOYS and CON EG, EEG 94/62. 

Murrough JW, Perez AM, Pillemer S, Stem J, Parides MK, aan het Rot M, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 2013 74 250-6. 

Drug-combination studies In a double-blind, placebo-controlled, randomised clinical study, the efficacy of methylfolate as adjunct therapy in the management of SSRI (serotonin-specific reuptake inhibitor)-resistant major depression was evaluated. No significant differences were observed in adverse events between the methylfolate and placebo groups [9 j. 

Papakostas Gl, Shelton RG, Zajecka JM, Etemad B, Rickels K, Clain A, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry December 1,2012 169(12) 1267-74. 

Resist major levels of earthquake ground motion without failure of the isolation system, without significant damage to structural elements and nonstructural components, and without major disruption of the function of the facility... 

PAFC needs to be maintained at temperatures above 60°C to prevent acid freezing leading to frozen acid crystals from getting inside the hydrophobic pores. Under operation, these crystals melt and remain inside the hydrophobic pore. Such blockages, can offer very high gas diffusion resistance. Major damage occurs to the PAFC stacks during the shutdown and startup only, and hence it should happen only a minimum number of times. 

---